In our study, we identified that the expression levels of CXCL2 in HNSCC tissue increased significantly when compared to normal tissue, and HNSCC patients with high CXCL2 expression were associated with poor RFS outcomes. Here, CXCL2 is linked to head and neck squamous cell carcinoma.